Avaliação do tratamento com anticorpos monoclonais : anti-CTLA4 (9H10) e anti- CD28 (PV-1) na esquistossomose mansônica murina

Avaliação do tratamento com anticorpos monoclonais : anti-CTLA4 (9H10) e anti- CD28 (PV-1) na esquistossomose mansônica murina

Made available in DSpace on 2016-08-17T18:39:44Z (GMT). No. of bitstreams: 1 4594.pdf: 3287424 bytes, checksum: 45ec60b0a38c4b296ddba2d66d8cd69c (MD5) Previous issue date: 2011-10-27 === Universidade Federal de Minas Gerais === Schistosomiasis mansoni is a major problem affecting public health, ac...

Full description

Bibliographic Details
Main Author:	Souza, Laís Cristina de
Other Authors:	Anibal, Fernanda de Freitas
Format:	Others
Language:	Portuguese
Published:	Universidade Federal de São Carlos 2016
Subjects:	Biotecnologia Moléculas coestimulatórias CTLA4 e CD28 Esquistossomose mansônica Tratamento anti-CTLA4 e anti-CD28 CD28 and CTLA4 molecules coestimulatory Schistosomiasis Anti-CTLA4 and anti-CD28 CIENCIAS BIOLOGICAS::IMUNOLOGIA
Online Access:	https://repositorio.ufscar.br/handle/ufscar/7005

Similar Items

BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01)

Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types
by: Damilola Oyewole-Said, et al.
Published: (2020-12-01)

CD28 co-stimulation in T-cell homeostasis: a recent perspective
by: Beyersdorf N, et al.
Published: (2015-05-01)

The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
by: Weixi Liu, et al.
Published: (2021-02-01)

Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis
by: Mohammad Javad Mousavi, et al.
Published: (2021-01-01)

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
by: Blagoje Soskic, et al.
Published: (2021-01-01)

Costimulatory blockade of the CD28 / CD80-86 / CTLA-4 balance in transplantation: impact on memory T cells?
by: Simon eVille, et al.
Published: (2015-08-01)

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
by: Amirali Karimi, et al.
Published: (2021-03-01)

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
by: David L. Bajor, et al.
Published: (2018-10-01)

Avaliação de polimorfismo em genes da família CD28 e suas associações com câncer de mama.
by: Araujo, Danebe Fernandes de [UNIFESP]
Published: (2015)

Polysaccharide of atractylodes macrocephala koidz activated T lymphocytes to alleviate cyclophosphamide-induced immunosuppression of geese through novel_mir2/CD28/AP-1 signal pathway
by: Wanyan Li, et al.
Published: (2021-07-01)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
by: Navid Sobhani, et al.
Published: (2021-03-01)

The Role of CD14 and CTLA4 Gene Polymorphisms in Risk of Celiac Disease among Patients of Iranian Ethnicity
by: Mahdi Zamani, et al.
Published: (2014-06-01)

sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection
by: Jil M. Jubel, et al.
Published: (2021-08-01)

High Inflammatory Tendency Induced by Malignant Stimulation Through Imbalance of CD28 and CTLA-4/PD-1 Contributes to Dopamine Neuron Injury
by: Dong L, et al.
Published: (2021-06-01)

Molecular alterations in the TCR signaling pathway in patients with aplastic anemia
by: Bo Li, et al.
Published: (2016-03-01)

The Association Between Single-Nucleotide Polymorphisms of Co-Stimulatory Genes Within Non-HLA Region and the Prognosis of Leukemia Patients With Hematopoietic Stem Cell Transplantation
by: Ding-Ping Chen, et al.
Published: (2021-10-01)

Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production
by: Kei Watari, et al.
Published: (2019-10-01)

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
by: Neil Halliday, et al.
Published: (2020-12-01)

Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves’ disease in a Chinese Han population
by: Xiaoming Chen, et al.
Published: (2018-09-01)

The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
by: Shashuang Zhang, et al.
Published: (2020-03-01)

Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy
by: Alimohammadi R, et al.
Published: (2020-07-01)

EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. A. Zhulai, et al.
Published: (2014-06-01)

Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies
by: Sonam Puri, et al.
Published: (2020-01-01)

PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
by: Jun Wang, et al.
Published: (2017-01-01)

A Model for Apoptotic-Cell-Mediated Adaptive Immune Evasion via CD80–CTLA-4 Signaling
by: Abraam M. Yakoub, et al.
Published: (2019-05-01)

The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment
by: A A Popova, et al.
Published: (2013-11-01)

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
by: Muhammad Zubair Afzal, et al.
Published: (2018-07-01)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
by: Shouheng Lin, et al.
Published: (2021-04-01)

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
by: Ribas Antoni, et al.
Published: (2012-11-01)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
by: Po-Chun Liu, et al.
Published: (2020-03-01)

The use of immunotherapy in the treatment of melanoma
by: Tala Achkar, et al.
Published: (2017-04-01)

Immunoprofiling for Prediction of Response to Abatacept in Rheumatoid Arthritis Patients
by: Prodromos Sidiropoulos, et al.
Published: (2016-01-01)

Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma
by: Arjun Khunger, et al.
Published: (2021-03-01)

Blocking Effect of Chaga Mushroom (<i>Inonotus oliquus</i>) Extract for Immune Checkpoint CTLA-4/CD80 Interaction
by: Tae In Kim, et al.
Published: (2020-08-01)

Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1
by: Yi-Chi eKong, et al.
Published: (2014-05-01)

Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
by: Bin Wang, et al.
Published: (2018-08-01)

Preponderance of CTLA4 Variation Associated With Autosomal Dominant Immune Dysregulation in the MYPPPY Motif
by: Owen M. Siggs, et al.
Published: (2019-07-01)

IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01)

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
by: Ahmad Tarhini, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_j4rbl7kqra5i2cqhndmmn19eki